Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Margoni

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmunology|September 14, 2019
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunityMonica Margoni, Antonio Carotenuto
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemicMonica Margoni, Paolo Gallo
Cephalalgia : an International Journal of Headache|July 6, 2011
Ketogenic diet in migraine treatment: a brief but ancient historyFerdinando Maggioni, Monica Margoni, Giorgio Zanchin
JAMA Neurology|March 23, 2026
Chronic Active Lesions in Pediatric Multiple SclerosisMonica Margoni, Maria A Rocca, Massimo Filippi
The Lancet. Neurology|June 14, 2024
Multiple sclerosis diagnosis: a biologically driven perspectiveMassimo Filippi, Monica Margoni, Maria A Rocca
Frontiers in Neurology|June 3, 2021
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and OpportunitiesMonica Margoni, Francesca Rinaldi, Paola Perini, et al.
Neurology and Therapy|June 30, 2018
Monitoring Progressive Multiple Sclerosis with Novel Imaging TechniquesMaria Petracca, Monica Margoni, Giulia Bommarito, et al.
Cephalalgia : an International Journal of Headache|October 12, 2012
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism?Ferdinando Maggioni, Chiara Briani, Monica Margoni, et al.
Journal of Neurology|August 12, 2021
Anti-CD20 therapies for multiple sclerosis: current status and future perspectivesMonica Margoni, Paolo Preziosa, Massimo Filippi, et al.
CNS Drugs|June 23, 2026
Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGADMonica Margoni, Paolo Preziosa, Maria A Rocca, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmunology|September 14, 2019
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunityMonica Margoni, Antonio Carotenuto
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemicMonica Margoni, Paolo Gallo
Cephalalgia : an International Journal of Headache|July 6, 2011
Ketogenic diet in migraine treatment: a brief but ancient historyFerdinando Maggioni, Monica Margoni, Giorgio Zanchin
JAMA Neurology|March 23, 2026
Chronic Active Lesions in Pediatric Multiple SclerosisMonica Margoni, Maria A Rocca, Massimo Filippi
The Lancet. Neurology|June 14, 2024
Multiple sclerosis diagnosis: a biologically driven perspectiveMassimo Filippi, Monica Margoni, Maria A Rocca
Frontiers in Neurology|June 3, 2021
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and OpportunitiesMonica Margoni, Francesca Rinaldi, Paola Perini, et al.
Neurology and Therapy|June 30, 2018
Monitoring Progressive Multiple Sclerosis with Novel Imaging TechniquesMaria Petracca, Monica Margoni, Giulia Bommarito, et al.
Cephalalgia : an International Journal of Headache|October 12, 2012
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism?Ferdinando Maggioni, Chiara Briani, Monica Margoni, et al.
Journal of Neurology|August 12, 2021
Anti-CD20 therapies for multiple sclerosis: current status and future perspectivesMonica Margoni, Paolo Preziosa, Massimo Filippi, et al.
CNS Drugs|June 23, 2026
Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGADMonica Margoni, Paolo Preziosa, Maria A Rocca, et al.
Pageof 8